However, since xenografts from tumors of different germ layers when transplanted as single cell suspensions are supported by a tumor vascular system originating from the host, and since CD13 on the tumor vascular cells is the main target for tTF-NGR, this synergistic effect may be also operative in models using other tumor histologies. This evidence concerns the gene RHOH and neoplasm.